【摘 要】
：
Enhanced external counterpulsation (EECP) is used to noninvasively treat refractory angina patients,including those with a history of heart failure.The International EECP Patient Registry was used to
【出 处】
：
中国老年学会体外反搏与心血管康复论坛暨第二届国际体外反搏学术交流会
论文部分内容阅读
Enhanced external counterpulsation (EECP) is used to noninvasively treat refractory angina patients,including those with a history of heart failure.The International EECP Patient Registry was used to examine the benefit and safety of EECP treatment,including a 6-month follow-up,in 1,957 patients,548 with a history of heart failure.The heart failure cohort was older,with more females,a greater duration of coronary artery disease,more prior infarcts and revascularizations.Significantly fewer heart failure patients completed the course of EECP,and exacerbation of heart failure was more frequent,though overall major adverse cardiac events (MACE,i.e.death,myocardial infarction,revascularization) during treatment were not significantly different.The angina class improved in 68%,with comparable quality of life benefit,in the heart failure cohort.
其他文献
Patients with coronary artery disease have a variety of treatment options available to them.These include medications to control anginal episodes and,when appropriate,revascularization interventions i
EECP is a non-invasive outpatient treatment for cardiovascular disease refractory to medical and/or surgical therapy.It has been cleared by the Food and Drug Administration for the treatment of a vari
The International Enhanced External Counterpulsation (EECP) Patient Registry tracks acute and long-term outcome for consecutive patients treated for chronic angina.Although EECP has previously been sh
Among 2,486 patients enrolled in the International EECP Patient Registry (IEPR) who underwent EECP therapy for symptomatic coronary artery disease,the median diastolic augmentation (DA) ratio increase
Enhanced external counterpulsation (EECP) has recently emerged as a treatment option for angina in selected patients suitable for revascularization with percutaneous coronary intervention (PCI).We com